Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2022 Feb 15;13:833040. doi: 10.3389/fimmu.2022.833040

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2022 Wang, Mo, Ou, Fang, Wu, Wu and Nandakumar

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

PMC Copyright notice

Effect of mmu-miR-96-5p on OC differentiation and apoptosis. (A) Effect of mmu-miR-96-5p mimic or inhibitor on OC formation. (B, C) Osteoclast apoptosis, (D, E) ROS production, and (F, G) mitochondrial membrane potential level after miR-96-5p mimic or inhibitor treatment. (H) Western blot analysis of caspase-3, Bcl-2, and Bax. (I) Cyto c expression in the cytoplasm and mitochondria with or without P.M OMV treatment. P.M, Proteus mirabilis. Scale bar = 200 μm. Data are from 3 independent experiments and given as mean ± SD. ^#p < 0.05 compared to NC mimic. ****p < 0.0001 compared to M-CSF+RANKL. *p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001 compared to the NC inhibitor. ns, not significant.